Juan Andres Pimentel-Esparza
Juan Andres Pimentel-Esparza has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Ezquerra-Osorio
Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
1 shared publication - Alexis Zambrano-Zambrano
Internal Medicine, National Medical Center November 20 ISSSTE, Mexico City, MEX
1 shared publication - Axel Rodriguez-Méndez
Cardiac Intensive Care Unit, National Institute of Cardiology, Mexico City, MEX
1 shared publication - Efrén Melano-Carranza
Cardiac Intensive Care Unit, National Institute of Cardiology, Mexico City, MEX
1 shared publication Jorge Antonio Cervantes-Nieto
Policlin Integral Bajio, Dept Cardiol, Irapuato, Mexico
1 shared publication- Jorge Antonio Cervantes-Nieto
Cardiology, PEMEX Regional Hospital Salamanca, Salamanca, MEX
1 shared publication
Latest Publications
- Open Access
- 26 January 2024
- Published by Springer Nature in Cureus
- Vol. 16 (1) , e52985
Massive Pulmonary Embolism Related to a Patient With Heart Failure Secondary to Stress Cardiomyopathy: A Case Report
Venous thromboembolism (VTE) is a common disease, which includes deep venous thrombosis (DVT) and pulmonary embolism (PE). It is the third most common cardiovascular disorder, affecting predominantly the male elderly population. Stress cardiomyopathy (SC) is a transitorily cardiovascular condition produced after an emotional or physical trigger, and it features signs and symptoms of acute coronary syndrome. Its pathophysiological mechanisms remain unclear, and SC has also been related to critical complications such as heart failure, arrhythmias, left ventricular outflow obstruction, and thromboembolic events. This case report highlights the association of PE and SC that might play a pathophysiological role.
- 26 January 2024
- Published by Springer Nature in Cureus
- Vol. 16 (1) , e52985
Open AccessMassive Pulmonary Embolism Related to a Patient With Heart Failure Secondary to Stress Cardiomyopathy: A Case Report
Venous thromboembolism (VTE) is a common disease, which includes deep venous thrombosis (DVT) and pulmonary embolism (PE). It is the third most common cardiovascular disorder, affecting predominantly the male elderly population. Stress cardiomyopathy (SC) is a transitorily cardiovascular condition produced after an emotional or physical trigger, and it features signs and symptoms of acute coronary syndrome. Its pathophysiological mechanisms remain unclear, and SC has also been related to critical complications such as heart failure, arrhythmias, left ventricular outflow obstruction, and thromboembolic events. This case report highlights the association of PE and SC that might play a pathophysiological role.
- Open Access
- 6 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33449
Coronary Artery Disease in Systemic Lupus Erythematosus: What Do the Facts Say?
Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect any organ with a predisposition for women of reproductive age. It is related to a higher risk of cardiovascular events, increasing it up to 50 times in young people, and 30% of deaths are attributed to coronary artery disease. The risk of developing cardiovascular disease in SLE is related not only to traditional cardiovascular risks factors such as advanced age, hypertension, dyslipidemia, and diabetes but also to disease-specific factors, such as degree of activity, autoantibodies, organ damage, and treatment. Accelerated atherosclerosis is one of the main contributors to pathogenesis. Manifestations range from angina to acute myocardial infarction and sudden death. Markers have been studied for the detection of subclinical disease and stratification of these patients, as well as different treatment options to improve the cardiovascular prognosis of the disease.
- 6 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33449
Open AccessCoronary Artery Disease in Systemic Lupus Erythematosus: What Do the Facts Say?
Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect any organ with a predisposition for women of reproductive age. It is related to a higher risk of cardiovascular events, increasing it up to 50 times in young people, and 30% of deaths are attributed to coronary artery disease. The risk of developing cardiovascular disease in SLE is related not only to traditional cardiovascular risks factors such as advanced age, hypertension, dyslipidemia, and diabetes but also to disease-specific factors, such as degree of activity, autoantibodies, organ damage, and treatment. Accelerated atherosclerosis is one of the main contributors to pathogenesis. Manifestations range from angina to acute myocardial infarction and sudden death. Markers have been studied for the detection of subclinical disease and stratification of these patients, as well as different treatment options to improve the cardiovascular prognosis of the disease.